Given the huge interest in our previous webinar on GARDskin Dose-Response, we are pleased to offer you a new opportunity to get to know this novel in vitro test.
The webinar will start with a recorded presentation followed by a live Q&A session. You will learn how the assay works and how it can help you with skin sensitizing potency ranking of candidate ingredients and early decision-making during product development.
- How GARDskin Dose-Response works.
- How the readouts correlate with LLNA EC3 values and human sensitizing potency categories.
- Examples of how the readout can be used depending on the customer-specific needs.
Andy Forreryd, PhD, SenzaGen AB
GARDskin Dose-Response at a glance
GARDskin Dose-Response is a novel in vitro test for quantitative potency assessment of chemicals, adapted from GARDskin.
GARDskin Dose-Response provides an estimated threshold concentration for a test substance to induce skin sensitizing effects (higher equaling a lower potency and vice versa). This threshold concentration can be used for skin sensitizing potency ranking of candidate ingredients and early decision-making during product development.
Additionally, the readout can be extrapolated to a correlating LLNA EC3 value, which is traditionally used to measure skin sensitizing potency of chemicals. Depending on the customer needs, it can also be extrapolated to a correlating Basketter Human Potency category (1-6) and/or GHS/CLP classification (1A or 1B) with high statistical significance.
What to know before attending the webinar?
The webinar will last around 30 minutes, followed by a live Q&A.
No required technical background on genomics, machine learning or programming.
If you can’t attend, still make sure to register! All registrants will receive the webinar materials afterwards.